CD86 and endometriosis: Here, rhIL-37 treatment significantly increased the proportion of CD40-, CD80-, CD86-, and MHC II-positive DCs in the blood of the mice with endometriosis, suggesting that rhIL-37 promoted DCs maturation in endometriosis.